Effect of ophthalmic solution components on acrylic intraocular lenses

J Cataract Refract Surg. 2007 Jan;33(1):122-6. doi: 10.1016/j.jcrs.2006.08.058.

Abstract

Purpose: To investigate the effect of ophthalmic solution components on the surface of acrylic intraocular lenses (IOLs).

Setting: Department of Opthalmology, Showa University School of Medicine.

Methods: Measurement of the contact angles of ophthalmic solutions on 3 acrylic IOLs was performed. The solutions were diclofenac sodium (Diclod), bromfenac sodium (Bronuck), betamethasone phosphate (Rinderon), dibekacin sulfate (Panimycin), polysorbate 80 (Tween 20), benzalkonium chloride, chlorobutanol, methylparahydroxybenzoate, and propylparahydroxybenzoate. The IOLs were incubated at 35 degrees C for 2 weeks in undiluted ophthalmic solutions and in 1:10 dilutions of ophthalmic solution components. The IOLs were sectioned and observed by scanning electron microscopy.

Results: The contact angle of Diclod and Bronuck solutions was the smallest. The contact angle of Rinderon and Panimycin was similar to that of distilled water. Scanning electron microscopy examination of IOLs incubated in ophthalmic solution components showed intralenticular changes. The IOLs immersed in ophthalmic solutions did not show any change, even after extended incubation.

Conclusion: The chemical components of ophthalmic solutions, such as surfactants and solvents, permeate acrylic IOLs, suggesting the potential for long-term adverse effects of eyedrops in pseudophakic eyes.

MeSH terms

  • Acrylic Resins*
  • Benzophenones / pharmacology
  • Betamethasone / pharmacology
  • Bromobenzenes / pharmacology
  • Dibekacin / pharmacology
  • Diclofenac / pharmacology
  • Lenses, Intraocular*
  • Microscopy, Electron, Scanning
  • Ophthalmic Solutions / pharmacology*
  • Solvents / pharmacology*
  • Surface-Active Agents / pharmacology*

Substances

  • Acrylic Resins
  • Benzophenones
  • Bromobenzenes
  • Ophthalmic Solutions
  • Solvents
  • Surface-Active Agents
  • Diclofenac
  • Dibekacin
  • bromfenac
  • Betamethasone